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Summary
Objectives: Peripheral blood mononuclear cells (PBMCs) increase after acute myocardial infarc-
tion (AMI) and inﬁltrate to the infarct region. However, its impact on left ventricular (LV)
remodeling remains unclear. The purpose of the present study was to clarify whether elevated
PBMC count contributed to LV remodeling in patients with AMI.
Subjects and methods: A total of 131 patients with AMI were recruited. White blood cell (WBC),
monocyte, and lymphocyte counts were measured at presentation and every 24 h for ﬁve days
after presentation. The correlation between PBMC count and LV remodeling was evaluated. LV
remodeling was deﬁned as an increase of LV end-diastolic volume index ≥10% at the 6-month
follow-up left ventriculography.
Results: Forty-eight patients had LV remodeling. Peak WBC (p = 0.008), peak monocyte
(p = 0.001), and peak PBMC (p < 0.001) counts were signiﬁcantly greater in patients with LV
remodeling than those without remodeling. Multivariate analysis revealed the peak PBMC count
3≥3600/mm was an independent predictor of LV remodeling [relative risk (RR) 3.243, p = 0.011].
Conclusion: Increased PBMC count is signiﬁcantly correlated with LV remodeling, thus suggesting
that PBMCs play a pivotal role for the development of LV remodeling after AMI.
© 2011 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Introduction
Left ventricular (LV) remodeling after acute myocardial
infarction (AMI) is characterized by progressive LV dilatation,
hypertrophy, distortion of cavity shape, and deterioration in
LV contractile function [1]. LV remodeling is associated with
the progression of heart failure and is an important determi-
nant of mortality [1,2]. The pathophysiological mechanisms
of LV remodeling after AMI are complex and dynamic.
Cytokines, such as tumor necrosis factor-, interleukin-1,
and interleukin-6 [3,4] and matrix metalloproteinases which
degrade the extracellular matrix [5—7], are major factors
for LV remodeling.
Peripheral blood mononuclear cells (PBMCs), deﬁned
as monocytes plus lymphocytes, are prevalent within the
necrotic myocardium after the onset of AMI [5,8,9].
Monocytes and macrophages are thought to be major
sources of proinﬂammatory cytokines [10] and matrix met-
alloproteinases [11]. The expression of these cytokines and
matrix metalloproteinases by monocytes are enhanced by
interferon-, which is produced by T lymphocytes or by
direct contact of monocytes with T lymphocytes [12—15].
Therefore, both monocytes and lymphocytes may play a
pivotal role in ventricular remodeling after AMI.
Many epidemiological studies have shown an elevated
peripheral white blood cell (WBC) count is associated with LV
remodeling [16]. The PBMC count may be more closely asso-
ciated with LV remodeling after AMI than the WBC count.
Therefore the aim of the present study was to investigate
whether elevated PBMC count contributed to LV remodeling
in patients with AMI and successful percutaneous coronary
intervention (PCI).
Patients and methods
Study population
A total of 397 consecutive patients with ST elevation
myocardial infarction treated with PCI were evaluated. All
patients were admitted to the Nippon Medical School Hos-
pital from January 1998 to December 2001. Among these
patients, 19 patients who died in the hospital, 1 with con-
nective tissue disease, 17 with renal failure, and 2 with
advanced liver disease were excluded. Those suspected of
having a malignant disease (7 patients) or any infectious
disease (5 patients) were also excluded.
The study inclusion criteria were (1) successful reperfu-
sion (ﬁnal Thrombolysis in Myocardial Infarction ﬂow grade
3 in the infarct-related coronary artery without any signif-
icant residual stenosis) within 12 h after the onset of AMI
(254 patients); (2) the patients who underwent coronary
arteriography and left ventriculography during both acute
phase and at 6 months after PCI; and (3) the infarct-related
artery had less than 50% luminal stenosis at 6 months (186
patients). ST elevation myocardial infarction was deﬁned as
(1) an increased creatine kinase (CK) level above twice the
upper limit of normal and (2) electrocardiographic changes
including ST segment elevation in at least two contiguous
leads and development of pathological Q waves. Finally, 131
patients were included in the present study.
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tudy protocol
he total and differential WBC including monocyte and lym-
hocyte counts were measured by an automated hematology
nalyzer (XE-2100, Sysmex, Kobe, Japan) at presentation
nd every 24 h for at least 5 days after the presentation.
he PBMC count was deﬁned as the sum of the monocyte
nd lymphocyte counts. Fasting plasma glucose, ﬁbrinogen,
otal cholesterol, triglyceride, and serum creatinine levels
ere measured after presentation and the data the closest
o presentation were used. The Killip classiﬁcation at pre-
entation, history of previous myocardial infarction and PCI,
oronary risk factors, and concomitant medications were
btained from the medical records.
The coronary angiography and left ventriculography ﬁnd-
ngs immediately after PCI and at 6 months after PCI
ere analyzed by two independent cardiologists without
nowledge of the patients’ characteristics. The LV ejection
raction and LV end-diastolic ventricular volume were mea-
ured by right anterior oblique projection of contrast left
entriculography at the time of and at 6 months after PCI
sing the area-length method.
LV remodeling was deﬁned as an increase in LV end-
iastolic volume index ≥10% during the 6 months follow-up
eriod. The present study protocol was in agreement with
uideline of institutional ethics committee, and informed
onsent was obtained in all patients before the cardiac
atheterization investigation.
tatistical analyses
ontinuous data are expressed as the mean value± SD. Com-
arison between two groups was performed by unpaired
-test or the Mann—Whitney analysis for continuous vari-
bles and by the chi-square test for categorical variables.
receiver operating characteristic analysis was performed
o determine the cut-off points of the peak WBC, peak neu-
rophil, peak monocyte, and peak PBMC counts and blood
hemical variables including fasting plasma glucose, peak
-reactive protein (CRP), and ﬁbrinogen levels for predict-
ng LV remodeling. A multiple logistic regression analysis
as performed to determine the effects of various variables
n LV remodeling. Variables with p-values <0.10 by univari-
te analyses were assessed further by a multiple logistic
egression analysis. The Statistical Package for Social Sci-
nce (SPSS) for Windows, version 11.0 (SPSS Inc., Chicago,
L, USA) was used for all statistical analyses. A p-value <0.05
as considered to be statistically signiﬁcant.
esults
atient characteristics
he reperfusion time was 7.31± 7.60 h. The peak WBC, peak
eutrophil, peak monocyte, and peak PBMC counts were
2,144± 3553/mm3, 9305± 2896/mm3, 852± 359/mm3,
nd 3453± 1317/mm3, respectively. The mean period from
he onset of AMI to the peak of PBMC count was 2± 1 days.
he patients were divided into two groups according to
he presence or absence of LV remodeling. As a result,
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Table 1 Clinical characteristics, blood chemical variables, medications, hemograms and coronary angiographic and left ven-
triculographic ﬁndings in patients with or without left ventricular remodeling.
Patients with remodeling (n = 48) Patients without remodeling (n = 83) p-value
Age (years) 64.0± 11.0 65.1± 10.9 0.588
Gender (M/F) 40/8 67/16 0.710
Killip’s class 1.2± 0.5 1.2± 0.6 0.946
Peak CK (IU/l) 2857± 2493 2304± 1989 0.379
FPG (mg/dl) 169± 61 138± 49 0.001
Fibrinogen (mg/dl) 472± 156 395± 129 0.003
Total cholesterol (mg/dl) 209± 41 213± 40 0.543
Triglyceride (mg/dl) 151± 66 143± 61 0.736
Serum creatinine (mg/dl) 1.06± 0.24 1.07± 0.52 0.318
Peak CRP (mg/dl) 12.0± 6.9 9.9± 6.7 0.060
ACEI or ARB use (%) 32/48 (66.7) 66/83 (79.5) 0.103
Beta-blocker use (%) 30/48 (62.5) 50/83 (60.2) 0.798
Aspirin or Ticlopidine use (%) 48/48 (100) 82/83 (98.8) 0.634
Statin use (%) 14/48 (29.2) 32/83 (38.6) 0.278
Peak WBC (/mm3) 13,290± 3824 11,482± 3227 0.008
Peak neutrophil (/mm3) 10,258± 3236 8755± 2541 0.009
Peak monocyte (/mm3) 1006± 415 764± 290 0.001
Peak PBMC (/mm3) 4104± 1552 3076± 989 <0.001
Reperfusion time (h) 7.2± 5.6 7.4± 8.6 0.460
Anterior infarction (%) 27/48 (56.3) 44/83 (53.0) 0.720
Collateral ≥grade 2 (%) 30/48 (62.5) 32/83 (38.6) 0.270
Number of diseased vessels 1.6± 0.8 1.6± 0.8 0.895
LVEF immediately after PCI (%) 51.3± 14.8 55.9± 12.3 0.054
LVEF at 6 months (%) 52.5± 14.9 61.0± 13.0 0.001
LVEDVI immediately after PCI (ml/m2) 71.0± 23.9 71.6± 20.4 0.832
LVEDVI at 6 months (ml/m2) 92.3± 30.0 61.1± 15.1 <0.001
Data are expressed as the mean value± SD or number of patients. ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II
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Areceptor blocker; CK, creatine kinase; CRP, C-reactive protein; FPG
index; LVEF, left ventricular ejection fraction; PBMC, peripheral bl
white blood cell.
8 patients had LV remodeling and 83 did not have LV
emodeling.
The peak WBC, peak neutrophil, peak monocyte, peak
BMC counts, and the levels of fasting plasma glucose and
brinogen were signiﬁcantly greater in the patients with LV
emodeling than those without remodeling (Table 1). The
eak CRP level had a tendency to be higher in patients with
V remodeling than those without LV remodeling, but these
id not reach statistical signiﬁcance (Table 1).
However, there were no signiﬁcant differences between
he two groups in terms of age, gender, Killip class, peak
K, total cholesterol, triglyceride, and serum creatinine
evels and medication use, including angiotensin-converting
nzyme inhibitors or angiotensin II receptor blockers, beta-
lockers, statins, and aspirin or ticlopidine (Table 1).
oronary angiographic and left ventriculographic
ndings
atients with LV remodeling had signiﬁcantly lower LV ejec-
ion fraction at 6 months after PCI in comparison to those
ithout LV remodeling and had a tendency to have lower
V ejection fraction immediately after PCI in comparison
o those without LV remodeling (Table 1). However, there
ere no signiﬁcant differences between the two groups with
c
p
≥
p
cting plasma glucose; LVEDVI, left ventricular end-diastolic volume
ononuclear cell; PCI, percutaneous coronary intervention; WBC,
espect to the reperfusion time after the onset of AMI, ante-
ior infarct location, the grade of collateral vessels (grade
2), and the number of diseased vessels (Table 1).
ut-off point of the peak PBMC for LV remodeling
he cut-off points of fasting plasma glucose and ﬁbrinogen
evels and peak WBC, peak neutrophil, peak monocyte, and
eak PBMC counts for LV remodeling were determined by a
eceiver operating characteristic analysis. The cut-off point
f peak PBMC for LV remodeling was 3620/mm3. Therefore,
600/mm3 was applied as the peak PBMC as the cut-off point
or the analyses in the present study. The cut-off points of
he fasting plasma glucose, peak CRP, ﬁbrinogen levels, and
eak WBC, peak neutrophil, and peak monocyte counts were
etermined in the same analyses.
redictors for LV remodeling
univariate analysis indicated that the fasting plasma glu-
ose level ≥130mg/dl, and peak WBC count ≥12,000/mm3,
eak monocyte count ≥830mg/dl and peak PBMC count
3600/mm3 were predictors for LV remodeling. A multi-
le logistic regression analysis revealed that the peak PBMC
ount ≥3600/mm3 [relative risk (RR) 3.86, 95% conﬁdence
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Table 2 Univariate and multiple logistic regression analysis for LV remodeling.
Univariate Multivariate analysis
p-value Relative risk 95% CI p-value
Peak PBMC ≥3600 (/mm3) <0.001 3.243 1.308—8.040 0.011
FPG ≥130 (mg/dl) 0.003 3.020 1.329—6.866 0.008
Peak monocyte ≥830 (/mm3) 0.001 2.741 0.995—7.554 0.051
Peak CRP ≥10.2 (/mm3) 0.095 1.417 0.606—3.316 0.422
Fibrinogen ≥410 (mg/dl) 0.067 1.377 0.592—3.201 0.458
Peak WBC ≥12,000 (/mm3) 0.017 1.198 0.196—7.333 0.845
Peak neutrophil ≥8900 (/mm3) 0.082 0.412 0.070—2.404 0.324
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blood cell.
interval (CI) 1.78—8.38, p = 0.011] and fasting plasma glu-
cose level ≥130mg/dl [RR 3.02, 95% CI 1.38—6.61, p = 0.006]
were independent predictors of LV remodeling (Table 2).
Discussion
The major ﬁnding of this study was that an elevated PBMC
count was an independent predictor of LV remodeling in
patients with AMI even if successfully treated by PCI.
After AMI, topographic change occurs in both the
infarcted and non-infarcted region. In the early phase, for
several days after the onset of AMI, ventricular thinning and
expansion progress in the infarcted region. Furthermore,
dilatation and eccentric hypertrophy of the viable region
also begin early and this process can continue long after
healing of the infarct [1].
Infarct healing is one of the key factors for ventricular
remodeling [1]. Inﬂammation after AMI has a signiﬁcant and
pivotal role in the infarct healing process which includes the
phagocytosis of necrotic tissues, degradation of extracellu-
lar matrix, replacement of collagen ﬁbers, and angiogenesis,
leading to repair and scar formation [4]. However, it is likely
that excessive inﬂammation after AMI exacerbates ventricu-
lar remodeling leading to chronic ventricular dilatation and
resulting in cardiac failure or cardiac rupture [17].
After the onset of AMI, inﬂammation is initiated from
the inﬁltration of monocytes and lymphocytes from the
circulating blood to the infarct region, followed by inﬁl-
tration of neutrophils [18]. Monocytes in the peripheral
blood will be maximized at 2 or 3 days after the onset of
AMI [19] and some of these inﬁltrate to the infarct region,
then differentiate to macrophages [10] and stay there
for several weeks. Macrophages phagocytise necrotic tis-
sues and produce matrix metalloproteinases, which degrade
the extracellular matrix. They also excrete inﬂammatory
cytokines such as tumor necrosis factor- and interleukin-6.
Tumor necorsis factor- induces apoptosis of myocytes in the
acute phase and enhances matrix metalloproteinase produc-
tion and activation, resulting in weakening and expanding of
the infarct region in the acute phase and global LV dilatation
in the late phase [4].
Lymphocytes also inﬁltrate the infarct region [5,8,9]
and mediate myocardial injury in vitro [20]. Interferon-
is produced by T helper 1 lymphocytes and Cheng et al.
r
a
d
f
tglucose; PBMC, peripheral blood mononuclear cell; WBC, white
21] found that the percentage of interferon- producing
cells in patients with AMI is signiﬁcantly higher than
hose in patients with stable angina or chest pain syn-
rome at 24 h after onset of the symptoms. Several studies
howed that interferon- exposure to monocytes, or direct
ontact between monocytes and T lymphocytes, enhances
he production of proinﬂammatory cytokines and matrix
etalloproteinases [12—15]. These data therefore suggest
he importance of both monocytes and lymphocytes for LV
emodeling after AMI.
Previous reports have shown an elevated plasma WBC
ount to be associated with LV remodeling [16] and Takahashi
t al. showed that LV end-diastolic and end-systolic volumes
t 4 weeks correlated positively with the admission neu-
rophil count [22]. Otherwise, Maekawa et al. showed that
he peak monocyte count has a signiﬁcant positive correla-
ion with the LV end-diastolic volume and a peak monocyte
ount ≥900mm3 is an independent determinant of pump
ailure, LV aneurysm, and long-term cardiac events [23],
nd Hong et al. also revealed that peak monocyte count
as the independent predictor of nonrecovery of LV func-
ion complicating AMI who underwent successful primary
CI [24]. However, it is possible that not only the mono-
yte count but also the lymphocyte count might contribute
o the LV remodeling. The current data suggested that an
levated PBMC count (the sum of the monocyte and lympho-
yte count) rather than the WBC count or only the monocyte
ount plays a pivotal role in the pathogenesis and devel-
pment of LV remodeling in patients with AMI successfully
reated with PCI.
This study also showed that elevated fasting plasma glu-
ose level was an independent predictor of LV remodeling.
tress hyperglycemia is a common feature in the early phase
f AMI and is associated with poor outcomes after AMI in
atient with and without diabetes [25,29,34]. Ishihara et al.
emonstrated that acute hyperglycemia was independently
ssociated with impaired LV function (and higher 30-day
ortality) after AMI [27]. In the early phase of AMI, serum
atecholamine, cortisol, free fatty acid and glucagon lev-
ls are elevated, leading to glucose intolerance and insulin
esistance, and furthermore insulin release from pancre-
tic islets is reduced [26]. Stress-related relative insulin
eﬁciency, increased lipolysis, elevated levels of circulating
ree fatty acids, and decreased myocardial glucose utiliza-
ion, all of which may have adverse effect on myocardial
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nergy metabolism and function in the presence of ischemia
28]. And recently, Marfella et al. [35] reported that tight
lycemic control after AMI reduces oxidative stress, inﬂam-
atory cell content, NFkB activation and pro-inﬂammatory
ytokine cell content and protects apoptosis in the ischemic
yocardium.
At the present time, ACEI or ARB is an essential drug
or the patients with AMI to prevent LV remodeling [31].
ngiotensin II induces expression of MCP-1 in mononuclear
ells. MCP-1 recruits inﬂammatory cells such as mono-
yte/macrophage. Recently, Kohno et al. reported that ARB
ttenuated MCP-1 expression, macrophage inﬁltration, and
yocardial ﬁbrosis in the border zone of post-infarction
yocardium [30]. In our study, ACEI or ARB use tended to
e higher in patients without LV remodeling as compared
ith those in patients with LV remodeling, but did not reach
tatistically signiﬁcance. That may be due to statistically
nder power because of few subjects.
Effective myocardial reperfusion may affect on accumu-
ation of monocytes and neutrophils in myocardium and LV
unction after AMI. Although a relationship between level
f myocardial reperfusion and monocytes/neutrophils count
as not investigated in the study, several studies indicated
hose relationship. Mariani et al. showed that low mono-
ytes and neutrophils count in patients with AMI treated with
CI were signiﬁcantly related to myocardial blush score and
T-segment resolution, which are reliable markers of effec-
ive myocardial reperfusion [32]. Liistro et al. also reported
hat thrombus aspiration in the setting of primary PCI in the
atients with AMI improved myocardial tissue-level perfu-
ion as well as LV functional recovery and remodeling [33].
ccordingly, thrombus aspirationmay reduce peakmonocyte
nd/or neutrophils, and improve LV functional recovery.
tudy limitations
irst, these data did not count the exact cell numbers of
nﬁltrating monocytes and lymphocytes in the myocardium
ut instead evaluated the indirect ﬁndings of circulating cell
umbers of monocytes and lymphocyte. Second, because
he actual levels of cytokines and matrix metalloproteinases
ere not measured, it was not clear whether the increased
irculating PBMCs were correlated with an elevation of
ytokines and matrix metalloproteinases. Third, despite
ymphocytes consisting of T-cells and B-cells, the lympho-
yte subsets were not measured, therefore the effect of
-cells on the ventricular remodeling was unclear.
onclusions
he present study demonstrated that an elevated PBMC
ount, but not just the WBC count or monocyte count and
he fasting plasma glucose level are independent predictors
or LV remodeling in patients with AMI successfully treated
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